Category Archives: November C;diff Awareness

November Is C. diff. Awareness Month: We Can Make a Difference Together Worldwide

In joint efforts with the C Diff Foundation Advocates and organizations dedicated in preventing and treating life-threatening Clostridioides difficile (C. diff., C. difficile) infections,  we express our gratitude and congratulate the State of Arizona, Arkansas, Idaho, Michigan, Minnesota, New Mexico,  Pennsylvania, West Virginia,  Wisconsin, to name a few, to date  for declaring November “Clostridioides difficile (C. diff., C. difficile) Awareness Month.

The Proclamations approved serve to heighten awareness of the impact this disease has on patients across the United States. The infection, which has been labeled an urgent national health threat by the Centers for Disease Control (CDC), results in 500,000 infections each year and is directly responsible for approximately 29,000 patients who died within 30 days of the initial diagnosis of C. difficile.  Of those, about 15,000 deaths were estimated to be directly attributable to C. difficile infections.

 

 

 

 

 

An excerpt from USA Today article published in 2012:    Deaths and illnesses are much higher than reports have shown. In March, the  CDC  said in a report that the C difficile infection kills 14,000 people a year. But that estimate is based on death certificates, which often don’t list the infection when patients die from complications, such as kidney failure.  Hospital billing data collected by the federal Agency for Healthcare Research and Quality shows that more than 9% of C. diff-related hospitalizations end in death — nearly five times the rate for other hospital stays. That adds up to more than 30,000 fatalities among the 347,000 C. diff hospitalizations in 2010. Thousands of patients are treated in nursing homes, clinics and doctors’ offices.

“We’re talking in the range of close to 500,000 total cases a year,” says Cliff McDonald, a C. diff expert, and senior science adviser in the CDC’s Division of Healthcare Quality Promotion. And annual fatalities “may well be … as high as 30,000.”

* AHRQ News and Numbers provides statistical highlights on the use and cost of health services and health insurance in the United States.

http://archive.ahrq.gov/news/newsroom/news-and-numbers/012512.html

In the USA:  Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released February 25, 2015, by the Centers for

Not only in November, but every day of the year it is our time to make a difference!  Most patients and their families, until their diagnosis, are not familiar with this infectious disease.  When they tell their friends and family, their friends and family have never heard of a C. difficile (Clostridium difficile, C. diff., CDI)  infection before.

Sometimes, even when they are told by their doctors of this diagnosis, the doctors can be largely unfamiliar with the impact of this infection and the treatments readily available. This is astonishing. Why? Because a C. diff. infection impacts individuals differently than it did decades ago.  The re-occurrence rate is greater today than it was in previous years.   C.difficile infections are not only acquired by a hospital stay but can be community-acquired.  It is a global diagnosis and this infection is not isolated in the senior population, however; seniors remain in the higher risk category of acquiring this infection.

FACT:  About a C. diff. infection  — Over 41 individuals lose their life to a Clostridioides difficile infection in the United States of America alone each day — C. difficile has no boundaries — It can be acquired by anyone –  at any location and at any age.

Every year we work together to change the level of C. difficile awareness worldwide. Every year we make a difference. Every day of every year we share information through education and advocacy for patients and continue to raise awareness of Clostridioides difficile infection (C. diff., C. difficile, CDI) prevention, treatments, clinical trials, and environmental safety  — further than the day before.

“None of us can do this alone – All of us can do this together.”

Clostridioides difficile (C. diff. C. difficile, CDI) has had an immeasurable impact on our families, in our communities, in our countries.  It is a leading Healthcare-associated infection (HAI) yet awareness of Clostridioides difficile remains quite low among the general public worldwide.

Help us change this.  Contact us and join us TODAY!

Take Action

  • Draft a letter to your State Governor requesting a Proclamation for November dedicated for promoting Clostridium difficile Infection Awareness.
  • Create Your Own Fundraiser!
  • Contact kathy@cdifffoundation.org to get started on the fundraiser of your choice.

Awareness Tools

  • Share the C Diff Foundation brochure  (request your copies by e-mail)  A great guide to explain details about a C. diff. infection and data on C. diff. prevention, treatments, and environmental safety available.
  • The Clinical Trials Page showcases Clostridium difficile prevention and treatment clinical trials available and research-driven results.
  • Personal Stories on C. diff. Survivors Alliance  allow you to share your story, to help raise awareness about C. difficile infections, and to help raise funds for C Diff Foundation www.cdifffoundation.org
  • Share  C.diff. Global Community Support session information which is FREE and available across the USA and accessible from 57 countries to learn more about a C. diff. infection, Nutrition, and to speak with health care providers and fellow-C.diff. survivors to gain knowledge and have questions answered.

Social Media Involvement

Please join us and share YOUR story. Use these November Awareness campaign hashtags to spread awareness for November Is Clostridioides difficile (Clostridium difficile, C.diff., C.difficile, CDI) Infection Awareness Month.

To obtain printed literature to share with your family, friends, colleagues, in your community and with your health care providers  — along with  a “November Is C. diff. Awareness Month”  Magnet, please contact the C Diff Foundation’s Main Office (727) 205-3922 or email your request:  info@cdifffoundation.org

#CdiffInfectionAwareness

(Facebook)  (Twitter)

#CdiffNovemberAwareness

(Facebook)  (Twitter)

# # # # # # # # # # # # # # # # # # # # # # #

NOVEMBER IS ALSO U.S. Antibiotics Awareness Week

November 18 – 24, 2019

 

 

 

CDC’s educational effort, Be Antibiotics Aware: Smart Use, Best Care, is the year-round effort to improve antibiotic prescribing and use and combat antibiotic resistance.

In November the  annual campaign  developed by the Centers for Disease Control and Prevention (CDC) :

Share the resources of countries Raising Antibiotic Awareness Worldwide

https://www.cdc.gov/antibiotic-use/week/get-involved.html

Antibiotic Awareness Week

https://www.england.nhs.uk/2019/10/world-antibiotic-awareness-week-18-22-november/

 

How do Antibiotics cause C. diff.?  The antibiotics cause a disruption in the normal intestinal flora which leads to an overgrowth of C. difficile bacteria in the colon. Leading antibiotics are known to disrupt the normal intestinal flora.

As far back as November 2012, the CDC started sharing a public announcement regarding antibiotic use: Colds and many ear and sinus infections are caused by viruses, not bacteria. Taking antibiotics to treat a “virus” can make those drugs less effective when you and your family really need them. Limiting the usage of antibiotics will also help limit new cases of CDI.
*Always discuss the symptoms and medications with the treating Physician/Healthcare Provider.

 

Your participation makes a BIG difference around the globe.

November IS C.diff. (Clostridium difficile, C.difficile) Infection Awareness Month – Changing Lives – Saving Lives – Making a Difference With You

YOU CAN make a difference!

How?

Let us show you the ways……

It is as simple as sharing a graphic provided below or by sharing the website which is complete with C.diff. Infection key points on  Prevention, Treatments available, Clinical Trials in progress, Environmental Safety, Infection Prevention, Support, Healthcare Provider updates, Patient and Family resources and much more.

www.cdifffoundation.org

The valuable information located on the website can answer questions that develop during a C.difficile infection.  The website also provides important contact information with  listings of free patient/family programs.

It is empowering to share the information through the printed literature available.  The information will be mailed  to a physical address (not e-mailed) and can be shared with friends, family, health care professionals, and within your community.

Having a conversation —- sharing your story, accompanied with the facts found on the website explaining C.diff. prevention, treatments available, clinical trials, environmental safety, and support worldwide, is both appreciated and powerful.

To receive complimentary brochures, magnets and additional information – please complete the form below:

You are invited to join us in advocating for Cdiff Awareness during the month of November and every month after that because educating and advocating  for C.diff. prevention, treatments available, clinical trials, environmental safety, and support is important every day of the year.

Become a Volunteer Patient Advocate today

Thank you for considering taking steps forward and walking with us to witness a global change and decrease in newly diagnosed Clostridium difficile infections worldwide.

With our sincere gratitude 💚

The Committee Chairs, Patient Advocates, and Members of the C Diff Foundation Worldwide

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  • Please Note:  ALL personal information submitted will never be shared or sold by the C Diff Foundation.  Name, Address, e-mail address will be utilized for the purpose set forth in this message.
  • Thank you .

 

CutisPharma Partners With C Diff Foundation To Support C.difficile Infection Awareness and Advocacy Efforts

 

CutisPharma and the C Diff Foundation announced the launch of a partnership beginning on November 1, 2017, the first day of Clostridium difficile awareness month.  As part of the partnership, CutisPharma awarded an unrestricted grant to the Foundation to further support its awareness efforts.

“We are pleased to partner with the C Diff Foundation and support its education and advocacy efforts benefiting patients impacted by Clostridium difficile Infection,” said Neal I. Muni, MD, MSPH, Chief Executive Officer of CutisPharma.  “It’s our hope that our work together can make positive strides in building awareness of this life-threatening condition that affects over a half-million patients in the United States annually.”

The nonprofit C Diff Foundation is dedicated to supporting global public health initiatives for Clostridium difficile Infection (CDI), also called C. difficile or C. diff – for infection prevention, treatments and environmental safety.

“We are very thankful for CutisPharma’s support of our foundation’s efforts,” said Nancy Caralla, Foundress and Executive Director of the C Diff Foundation, who is both a nurse and a three-time C. difficile survivor who also lost her father to a C. difficile infection.  “CutisPharma’s mission to improve the lives of patients with unmet medical needs is aligned with our foundation’s goals, and we look forward to partnering with Neal and his team to further our education and advocacy efforts on behalf of patients and survivors.”

CutisPharma has undertaken several initiatives to expand from its traditional base of making compounding kits for pharmacists, including the development and commercialization of FDA-approved drugs. The filing of the Company’s first FDA New Drug Application earlier this year, by its RM Therapeutics subsidiary, was a key milestone in the Company’s expansion goals.

About CutisPharma

CutisPharma, Inc., based in Wilmington, Mass., is a privately held, specialty pharmaceutical company that has historically developed and distributed kits used by pharmacists to safely create compounded medications for nearly 20 years.  The Company’s products include oral solutions and suspensions, such as antimicrobials, mouthwashes, and PPIs; topicals, including hydrocortisone; and suppositories, including progesterone VGS.  CutisPharma’s FIRST Unit-of-Use Kits have benefited millions of patients who are unable to swallow conventional oral dosage forms such as tablets and capsules and whose needs are not served by commercially available therapies.  For more information, visit www.cutispharma.com.

C Diff Foundation Welcomes Denise Graham, Assistant Public Relations

We are pleased to welcome Denise Graham
to the C Diff Foundation.

Denise Graham, Founder and President of DDG Associates, formerly the Executive Vice President to the Association for Professionals in Infection Control (APIC) and Epidemiology, led the nation’s public reporting initiative thereby enabling her to work closely with all agencies falling under the U.S. Department of Health and Human Services.  Her expertise in this arena continues by assisting clients with ongoing changes such as value-based purchasing and guidelines coming from the Centers for Disease Control and Prevention (CDC).

With greater than twenty years of experience in the healthcare industry, Denise has formed key working relationships with numerous leading experts.

Denise comes to the C Diff Foundation as Assistant Public Relations Coordinator  to introduce the organization with greater visibility and continued growth in educating and advocating for C.difficile Infection prevention, treatments, environmental safety and support worldwide.

To contact Denise:, please e-mail her at:    denise@cdifffoundation.org

C Diff Foundation Announces Scholarship Program to Support Health Care Students Worldwide

C Diff Foundation is pleased to announce the Michael and Helen Caralla, Sr. Educational Scholarship program. The scholarship program is to help health care students succeed and reach their educational goals.

Michael and Helen Caralla, Sr.
To apply for a C Diff Foundation
Michael and Helen Caralla, Sr. Educational Scholarship,
the applicant must submit an application
by May 1 of each calendar year.

 

 

 

 

 

The C Diff Foundation selection committee chooses application recipients based on a submitted essay, letters of recommendation, a willingness to complete the Volunteer Service project to promote C. difficile infection awareness requirement, and financial need.

Awards consist of annual scholarships that range in value from $750 to $1,500 USD.   Recipients must reapply each year they attend post-secondary school and will be chosen based on their academic progress and mentoring performance.

To be eligible for a Michael and Helen Caralla, Sr. Educational Scholarship the applicant must be:

  • A student and a high school graduate or have a General Educational Development a.k.a. General Educational Diploma (GED).
  • Enrolled full-time at an accredited post-secondary educational institution during the 2017-2018 academic year (If a foreign student is applying and is chosen, the educational scholarship awarded amount will be converted from USD to the educational institute location foreign currency exchange rate and proof of country residency must be provided).
  • Maintain full-time status throughout the 2017-2018 academic year in order to remain eligible.
  • Willing to complete a minimum of 50 volunteer hours promoting C. difficile infection prevention, treatments, and environmental safety awareness in their local communities per academic year awarded the educational scholarship.

C. difficile infections can be acquired and diagnosed in infants and across the life-span with a higher risk involving our senior citizens and that is why it is imperative to learn about a C. difficile infection, its most common symptoms, the treatments available, and environmental safety products to prevent the spread of this spore-bacteria and to help reduce C. difficile infection recurrences.

“When you apply to become a C Diff Foundation Scholar, you are taking the first step to determine your own future. The C Diff Foundation Scholars are individuals motivated and dedicated to making a difference in the health care community. We are excited to offer a scholarship program to help support health care students to advance their career path through the Michael and Helen Caralla, Sr. educational scholarship, a program in memory of our loving parents,” states Nancy C Caralla, Executive Director.

About the C Diff Foundation:
The C Diff Foundation, a 501(c)(3) non-profit, founded in 2012 by Nancy C Caralla, a nurse diagnosed and treated for Clostridium difficile (C. diff.) infections.

Through her own CDI journeys and witnessing the passing of her father, diagnosed with sepsis secondary to C. difficile infection involvement, Nancy recognized the need for greater awareness through education, the research being conducted by the government, industry, and academia and better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this devastating infection.

For additional Scholar Applicant information, visit the C Diff Foundation website

https://cdifffoundation.org/scholarship-eligibility/

Media Coordinator:
Denise Graham, RN
denise@cdifffoundation.org

Twitter: @cdiffFoundation #CdiffScholar